Stefan Matecki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Stefan Matecki has a total of 295 co-authors. Here are the top co-authors by number of shared publications:
- Alain Lacampagne
PhyMedExp, University of Montpellier, INSERM, CNRS
7 shared publications - Pascal Amedro
Pediatric and Congenital Cardiology, M3C National CHD Reference Centre, CHU de Bordeaux, Pessac, France, France
6 shared publications Boris Jung
PhyMedExp University of Montpellier, INSERM U1046, CNRS UMR 9214 Montpellier France
4 shared publicationsGregoire De La Villeon
Department of Specialized Pediatrics, Unit of Pediatric Cardiology and Nephrology, Montpellier University Hospital, France
4 shared publications- Arthur Gavotto
Department of Neonatal Medicine, Pediatric Intensive Care, Pediatric Emergency Transport Service, Arnaud de Villeneuve Hospital, Montpellier University Hospital Centre, University of Montpellier, Montpellier, France
3 shared publications Camille Soulatges
Pediatric and Congenital Cardiology Department, M3C Regional Reference CHD Centre, APHM La Timone Hospital , Marseille , France
3 shared publications
Latest Publications
- Open Access
- 27 August 2026
- Published by Elsevier in SSRN Electronic Journal
Early Years Matter: Effects of Elexacaftor-Tezacaftor-Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years
Background: Data are missing regarding efficiency of elexacaftor/tezacaftor/ivacaftor (ETI) on lung disease evolution in preschool children with CF (PSCwCF).Methods: 211 PSCwCF were enrolled in a prospective study to assess key CF outcomes during their first year of ETI therapy, including sweat chloride concentration (SCC), fecal elastase, sputum microbiology and Forced Expiratory Volume in one second percentage predicted (ppFEV1). Bronchial structural changes were assessed with Chest Tomography (CT) at baseline and 1 year. Neutrophil elastase, calprotectin, IL-1β, IL-6, IL-8 and TNF-α concentrations were measured in sputum secretions.Findings: 111 PSCwCF (55%) decreased SCC below the 30 mmol/l normal threshold. ETI induced a significant weight gain by 0.15 [0.07, 0.22] z-score (p=0.0023) and fecal elastase increased from 113(203) to 167(232) (n=74; p<0.001). The number of patients negative for P.aeruginosa increased from 164 (78%) to 191 (91%) (p=0.0004) and that of patients negative for Staphylococcus.aureus increased from 73 (35%) to 94 (45%) (p=0.0017). ppFEV1 increased by 17.8 [6.9 , 28.7] (p< 0.0001, n=71). Mucus plug number decreased to a non-detectable signal. The ratio of bronchial wall area to the outer bronchial area, which reflects bronchial inflammation, decreased significantly (p=0.0002) while that of outer bronchial diameter, a marker of bronchial dilatation, remained stable. These improvements were associated with a significant reduction in sputum inflammatory markers.Conclusion: ETI modifies the trajectory of lung CF disease progression in PSCwCF, with sustained improvements in bronchial wall thickness, mucus plug number, airway inflammation and infection.
- 27 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEarly Years Matter: Effects of Elexacaftor-Tezacaftor-Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years
Background: Data are missing regarding efficiency of elexacaftor/tezacaftor/ivacaftor (ETI) on lung disease evolution in preschool children with CF (PSCwCF).Methods: 211 PSCwCF were enrolled in a prospective study to assess key CF outcomes during their first year of ETI therapy, including sweat chloride concentration (SCC), fecal elastase, sputum microbiology and Forced Expiratory Volume in one second percentage predicted (ppFEV1). Bronchial structural changes were assessed with Chest Tomography (CT) at baseline and 1 year. Neutrophil elastase, calprotectin, IL-1β, IL-6, IL-8 and TNF-α concentrations were measured in sputum secretions.Findings: 111 PSCwCF (55%) decreased SCC below the 30 mmol/l normal threshold. ETI induced a significant weight gain by 0.15 [0.07, 0.22] z-score (p=0.0023) and fecal elastase increased from 113(203) to 167(232) (n=74; p<0.001). The number of patients negative for P.aeruginosa increased from 164 (78%) to 191 (91%) (p=0.0004) and that of patients negative for Staphylococcus.aureus increased from 73 (35%) to 94 (45%) (p=0.0017). ppFEV1 increased by 17.8 [6.9 , 28.7] (p< 0.0001, n=71). Mucus plug number decreased to a non-detectable signal. The ratio of bronchial wall area to the outer bronchial area, which reflects bronchial inflammation, decreased significantly (p=0.0002) while that of outer bronchial diameter, a marker of bronchial dilatation, remained stable. These improvements were associated with a significant reduction in sputum inflammatory markers.Conclusion: ETI modifies the trajectory of lung CF disease progression in PSCwCF, with sustained improvements in bronchial wall thickness, mucus plug number, airway inflammation and infection.
- Open Access
- 12 August 2026
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 17 (4)
Changes in Muscle Mass and Quality Mediate the Effect of High‐Calorie Intake on Clinical Outcomes
Background: Critically ill patients frequently experienced acquired muscle dysfunction, which adversely affects outcomes. The relationship between calorie intake, muscle dysfunction and outcomes remains unclear. This study aims to determine if early calorie intake affects patients' outcomes through changes in skeletal muscle mass or quality, and to explore changes in muscle structure and underlying molecular pathways using limb muscle biopsies in a piglet model. Methods: This translational study combines data from a prospective observational study including critically ill patients and a 72‐h ventilated piglet model with early high calorie full enteral nutrition, both recording serial ultrasound measurements of limb muscle thickness and stiffness. Patients were classified into two trajectory groups based on thickness, stiffness and calorie intake. Adjusted mediation analysis quantified the effect of calorie intake on outcomes explained by muscle trajectories. The primary endpoint was ventilator‐free days at Day 28 (VFD28). In vivo limb muscle biopsies from piglets were analysed. Results: Among 102 patients, 21% and 28% exhibited decreased thickness and stiffness by Day 7, respectively; 36% received high‐calorie intake at Day 7. Patients categorized into the ‘decreased trajectory group’ for both thickness and stiffness showed lower VFD28 ( p < 0.01) and longer ICU stay ( p < 0.01) compared to the ‘stable trajectory group’. High‐calorie intake was associated with significantly lower VFD28 (−8.7 days [−14.7 to −1.7]; p = 0.01), longer ICU stay ( p < 0.01) and higher ICU mortality ( p < 0.01). Decreased muscle trajectories mediated, respectively, 42% and 28% of the association between high‐calorie intake and VFD 28. The porcine model showed a limb muscle stiffness reduction associated with muscle fibre atrophy and increased intramuscular lipid content linked to decreased protein synthesis (IGF‐1 and myostatin downregulation), increased autophagy (ATG5, ATG7 and P62 increased activity) and impaired fatty acid metabolism (carnitine palmitoyltransferase 1B reduced expression). Conclusions: This study demonstrates that early calorie intake in critically ill patients adversely affects muscle mass and quality, mediating negative outcomes. The porcine model helps elucidate underlying mechanisms, with early high‐calorie intake resulting in a metabolic oversupply state associated with metabolic disorders leading to muscle fibre atrophy and lipid accumulation. These results highlight the importance of targeted nutritional strategies to preserve muscle health in critically ill patients.
- 12 August 2026
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 17 (4)
Open AccessChanges in Muscle Mass and Quality Mediate the Effect of High‐Calorie Intake on Clinical Outcomes
Background: Critically ill patients frequently experienced acquired muscle dysfunction, which adversely affects outcomes. The relationship between calorie intake, muscle dysfunction and outcomes remains unclear. This study aims to determine if early calorie intake affects patients' outcomes through changes in skeletal muscle mass or quality, and to explore changes in muscle structure and underlying molecular pathways using limb muscle biopsies in a piglet model. Methods: This translational study combines data from a prospective observational study including critically ill patients and a 72‐h ventilated piglet model with early high calorie full enteral nutrition, both recording serial ultrasound measurements of limb muscle thickness and stiffness. Patients were classified into two trajectory groups based on thickness, stiffness and calorie intake. Adjusted mediation analysis quantified the effect of calorie intake on outcomes explained by muscle trajectories. The primary endpoint was ventilator‐free days at Day 28 (VFD28). In vivo limb muscle biopsies from piglets were analysed. Results: Among 102 patients, 21% and 28% exhibited decreased thickness and stiffness by Day 7, respectively; 36% received high‐calorie intake at Day 7. Patients categorized into the ‘decreased trajectory group’ for both thickness and stiffness showed lower VFD28 ( p < 0.01) and longer ICU stay ( p < 0.01) compared to the ‘stable trajectory group’. High‐calorie intake was associated with significantly lower VFD28 (−8.7 days [−14.7 to −1.7]; p = 0.01), longer ICU stay ( p < 0.01) and higher ICU mortality ( p < 0.01). Decreased muscle trajectories mediated, respectively, 42% and 28% of the association between high‐calorie intake and VFD 28. The porcine model showed a limb muscle stiffness reduction associated with muscle fibre atrophy and increased intramuscular lipid content linked to decreased protein synthesis (IGF‐1 and myostatin downregulation), increased autophagy (ATG5, ATG7 and P62 increased activity) and impaired fatty acid metabolism (carnitine palmitoyltransferase 1B reduced expression). Conclusions: This study demonstrates that early calorie intake in critically ill patients adversely affects muscle mass and quality, mediating negative outcomes. The porcine model helps elucidate underlying mechanisms, with early high‐calorie intake resulting in a metabolic oversupply state associated with metabolic disorders leading to muscle fibre atrophy and lipid accumulation. These results highlight the importance of targeted nutritional strategies to preserve muscle health in critically ill patients.
- 22 July 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (10) , 1719-1732
Early and Stage-Dependent Cardiopulmonary Fitness Impairment in Pediatric CKD
Key Points: Children with CKD exhibit markedly lower cardiopulmonary fitness with an absolute maximal oxygen uptake deficit of 10 ml/kg per minute compared with reference values. More than half of the patients show impaired fitness as early as CKD stage 3, highlighting early functional vulnerability. Maximal oxygen uptake is independently associated with modifiable parameters commonly targeted by rehabilitation, supporting tailored intervention strategies. Background: Children with CKD are at high cardiovascular risk, yet cardiopulmonary fitness is rarely assessed in routine care. Maximal oxygen uptake (VO 2 max) is a powerful prognostic marker, and Z -score–based evaluations may improve early risk stratification. Methods: In this prospective multicenter study, children aged 6–17 years with CKD stages 2–5 (Kidney Disease Improving Global Outcome) underwent standardized cardiopulmonary exercise testing (CPET). VO 2 max was expressed as Z -scores using contemporary pediatric reference values. Impaired fitness was defined as VO 2 max Z -score <–1.64. Multivariable linear regression was used to identify independent determinants of VO 2 max. Results: Among 88 enrolled patients (mean age 12±4 years, 67% male), 77 completed a valid CPET. Mean VO 2 max Z -score was −1.8±2.1, corresponding to 33.5±9.2 ml/kg per minute, that is, an absolute lowering of approximately 10 ml/kg per minute compared with age-matched and sex-matched reference values. Overall, 57% had impaired fitness. VO 2 max was progressively lower across higher CKD stages ( P < 0.001 ). In multivariable analysis, higher VO 2 max was independently associated with higher hemoglobin concentration, better pulmonary function (forced expiratory volume in 1 s), better ventilatory efficiency (VE/VCO 2 slope), and higher ventilatory anaerobic threshold, explaining 77% of VO 2 max variability. Conclusions: Cardiopulmonary fitness is markedly lower in children with CKD, with a clear stage-dependent decline that is already evident at early disease stages. The magnitude of VO 2 max impairment is substantial and related to potentially modifiable clinical and functional factors, supporting early CPET-based screening and the development of targeted, multidisciplinary rehabilitation in pediatric CKD. Clinical Trial registry name and registration number: Clinicaltrials.gov identifier NCT04897672 and Montpellier University Hospital Institutional Review Board (IRB 202100852).
- 22 July 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (10) , 1719-1732
Early and Stage-Dependent Cardiopulmonary Fitness Impairment in Pediatric CKD
Key Points: Children with CKD exhibit markedly lower cardiopulmonary fitness with an absolute maximal oxygen uptake deficit of 10 ml/kg per minute compared with reference values. More than half of the patients show impaired fitness as early as CKD stage 3, highlighting early functional vulnerability. Maximal oxygen uptake is independently associated with modifiable parameters commonly targeted by rehabilitation, supporting tailored intervention strategies. Background: Children with CKD are at high cardiovascular risk, yet cardiopulmonary fitness is rarely assessed in routine care. Maximal oxygen uptake (VO 2 max) is a powerful prognostic marker, and Z -score–based evaluations may improve early risk stratification. Methods: In this prospective multicenter study, children aged 6–17 years with CKD stages 2–5 (Kidney Disease Improving Global Outcome) underwent standardized cardiopulmonary exercise testing (CPET). VO 2 max was expressed as Z -scores using contemporary pediatric reference values. Impaired fitness was defined as VO 2 max Z -score <–1.64. Multivariable linear regression was used to identify independent determinants of VO 2 max. Results: Among 88 enrolled patients (mean age 12±4 years, 67% male), 77 completed a valid CPET. Mean VO 2 max Z -score was −1.8±2.1, corresponding to 33.5±9.2 ml/kg per minute, that is, an absolute lowering of approximately 10 ml/kg per minute compared with age-matched and sex-matched reference values. Overall, 57% had impaired fitness. VO 2 max was progressively lower across higher CKD stages ( P < 0.001 ). In multivariable analysis, higher VO 2 max was independently associated with higher hemoglobin concentration, better pulmonary function (forced expiratory volume in 1 s), better ventilatory efficiency (VE/VCO 2 slope), and higher ventilatory anaerobic threshold, explaining 77% of VO 2 max variability. Conclusions: Cardiopulmonary fitness is markedly lower in children with CKD, with a clear stage-dependent decline that is already evident at early disease stages. The magnitude of VO 2 max impairment is substantial and related to potentially modifiable clinical and functional factors, supporting early CPET-based screening and the development of targeted, multidisciplinary rehabilitation in pediatric CKD. Clinical Trial registry name and registration number: Clinicaltrials.gov identifier NCT04897672 and Montpellier University Hospital Institutional Review Board (IRB 202100852).
- Open Access
- 11 June 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 304
Large language models for optimizing clinical trial recruitment in ICUs: application to ventilator-induced diaphragm dysfunction
Ventilator-induced diaphragm dysfunction (VIDD) is a frequent and under-recognized consequence of prolonged mechanical ventilation in intensive-care unit (
- 11 June 2026
- Published by Springer Nature in Critical Care
- Vol. 30 (1) , 304
Open AccessLarge language models for optimizing clinical trial recruitment in ICUs: application to ventilator-induced diaphragm dysfunction
Ventilator-induced diaphragm dysfunction (VIDD) is a frequent and under-recognized consequence of prolonged mechanical ventilation in intensive-care unit (
- Open Access
- 25 April 2026
- Published by Wiley in Muscle & Nerve
- Vol. 74 (1) , 255-264
Asynchrony Related to Mechanical Ventilation Exacerbates Diaphragm Dysfunction in a Mouse Model of Duchenne Muscular Dystrophy
Introduction/Aims: In dystrophic mice ( mdx , a genetic homolog of Duchenne muscular dystrophy: DMD), previous studies showed that mechanical ventilation (MV) induces ventilator‐induced diaphragmatic dysfunction (VIDD). However, susceptibility to mechanical stress caused by asynchrony remains unknown. Our aims were to investigate whether MV exacerbates diaphragm vulnerability to eccentric stress and to evaluate the role of RyR1 remodeling and NOX2 activation. Methods: Male mdx and wild‐type (WT) mice (10–12 weeks) were assigned to non‐ventilated or 6‐h MV groups. Diaphragm strength and susceptibility to eccentric contractions mimicking asynchrony were assessed, along with remodeling of the Ca 2+ release channel RyR1. Two preventive strategies were tested: in vivo S107 treatment (RyR1‐stabilizing compound) administered before MV; and in vitro incubation of diaphragms previously ventilated with S107 or ebselen (NOX2 inhibitor) just before eccentric stress. Results: MV reduced maximal tetanic force by 20.1% in WT and 27.0% in mdx mice without sarcolemmal injury. In mdx mice MV significantly increased susceptibility to eccentric contraction, causing a 45% greater force deficit and increased sarcolemmal damage. Pretreatment with S107 prevented both MV‐induced weakness and eccentric stress susceptibility. After 6 h MV, incubation with S107 or ebselen mitigated susceptibility to eccentric contraction. RyR1 oxidation, phosphorylation, and calstabin1 dissociation induced by MV were exacerbated by eccentric stress; S107 preserved calstabin1 binding, while ebselen reduced RyR1 oxidative modifications. Discussion: MV exacerbates diaphragm vulnerability to mechanical stress in dystrophin‐deficient muscle through RyR1 remodeling and NOX2 activation. Preventing asynchrony and targeting RyR1 or NOX2 may represent therapeutic strategies to limit respiratory complications in DMD.
- 25 April 2026
- Published by Wiley in Muscle & Nerve
- Vol. 74 (1) , 255-264
Open AccessAsynchrony Related to Mechanical Ventilation Exacerbates Diaphragm Dysfunction in a Mouse Model of Duchenne Muscular Dystrophy
Introduction/Aims: In dystrophic mice ( mdx , a genetic homolog of Duchenne muscular dystrophy: DMD), previous studies showed that mechanical ventilation (MV) induces ventilator‐induced diaphragmatic dysfunction (VIDD). However, susceptibility to mechanical stress caused by asynchrony remains unknown. Our aims were to investigate whether MV exacerbates diaphragm vulnerability to eccentric stress and to evaluate the role of RyR1 remodeling and NOX2 activation. Methods: Male mdx and wild‐type (WT) mice (10–12 weeks) were assigned to non‐ventilated or 6‐h MV groups. Diaphragm strength and susceptibility to eccentric contractions mimicking asynchrony were assessed, along with remodeling of the Ca 2+ release channel RyR1. Two preventive strategies were tested: in vivo S107 treatment (RyR1‐stabilizing compound) administered before MV; and in vitro incubation of diaphragms previously ventilated with S107 or ebselen (NOX2 inhibitor) just before eccentric stress. Results: MV reduced maximal tetanic force by 20.1% in WT and 27.0% in mdx mice without sarcolemmal injury. In mdx mice MV significantly increased susceptibility to eccentric contraction, causing a 45% greater force deficit and increased sarcolemmal damage. Pretreatment with S107 prevented both MV‐induced weakness and eccentric stress susceptibility. After 6 h MV, incubation with S107 or ebselen mitigated susceptibility to eccentric contraction. RyR1 oxidation, phosphorylation, and calstabin1 dissociation induced by MV were exacerbated by eccentric stress; S107 preserved calstabin1 binding, while ebselen reduced RyR1 oxidative modifications. Discussion: MV exacerbates diaphragm vulnerability to mechanical stress in dystrophin‐deficient muscle through RyR1 remodeling and NOX2 activation. Preventing asynchrony and targeting RyR1 or NOX2 may represent therapeutic strategies to limit respiratory complications in DMD.
- Open Access
- 3 February 2025
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 25 (6) , 1586-1599
A new biofunctionalized and micropatterned PDMS is able to promote stretching induced human myotube maturation
We use laser printing on organic–inorganic material and PDMS to study mechanical stress effect on human muscle cells. This model improves cell alignment and provide insights into muscle cell behavior under stress.
- 3 February 2025
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 25 (6) , 1586-1599
Open AccessA new biofunctionalized and micropatterned PDMS is able to promote stretching induced human myotube maturation
We use laser printing on organic–inorganic material and PDMS to study mechanical stress effect on human muscle cells. This model improves cell alignment and provide insights into muscle cell behavior under stress.
- Open Access
- 2 March 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (16) , 1458-1473
Early hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial
Cardiopulmonary fitness in congenital heart disease (CHD) decreases faster than in the general population resulting in impaired health-related quality of life (HRQoL). As the standard of care seems insufficient to encourage and maintain fitness, an early hybrid cardiac rehabilitation programme could improve HRQoL in CHD. The QUALIREHAB multicentre, randomized, controlled trial evaluated and implemented a 12-week centre- and home-based hybrid cardiac rehabilitation programme, including multidisciplinary care and physical activity sessions. Adolescent and young adult CHD patients with impaired cardiopulmonary fitness were randomly assigned to either the intervention (i.e. cardiac rehabilitation) or the standard of care. The primary outcome was the change in HRQoL from baseline to 12-month follow-up in an intention-to-treat analysis. The secondary outcomes were the change in cardiovascular parameters, cardiopulmonary fitness, and mental health. The expected number of 142 patients was enroled in the study (mean age 17.4 ± 3.4 years, 52% female). Patients assigned to the intervention had a significant positive change in HRQoL total score [mean difference 3.8; 95% confidence interval (CI) 0.2; 7.3; P = .038; effect size 0.34], body mass index [mean difference −0.7 kg/m2 (95% CI −1.3; −0.1); P = .022; effect size 0.41], level of physical activity [mean difference 2.5 (95% CI 0.1; 5); P = .044; effect size 0.39], and disease knowledge [mean difference 2.7 (95% CI 0.8; 4.6); P = .007; effect size 0.51]. The per-protocol analysis confirmed these results with a higher magnitude of differences. Acceptability, safety, and short-time effect of the intervention were good to excellent. This early hybrid cardiac rehabilitation programme improved HRQoL, body mass index, physical activity, and disease knowledge, in youth with CHD, opening up the possibility for the QUALIREHAB programme to be rolled out to the adult population of CHD and non-congenital cardiac disease. The long-term beneficial effect of the 12-week centre-based and home-based hybrid cardiac rehabilitation programme on adolescents and young adults with CHD was observed on HRQoL (primary outcome), BMI, physical activity, and disease knowledge, opening up the possibility for the QUALIREHAB programme to be rolled out to the adult population of CHD and non-congenital cardiac disease. BMI, body mass index; CHD, congenital heart disease; HRQoL, health-related quality of life.
- 2 March 2024
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (16) , 1458-1473
Open AccessEarly hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial
Cardiopulmonary fitness in congenital heart disease (CHD) decreases faster than in the general population resulting in impaired health-related quality of life (HRQoL). As the standard of care seems insufficient to encourage and maintain fitness, an early hybrid cardiac rehabilitation programme could improve HRQoL in CHD. The QUALIREHAB multicentre, randomized, controlled trial evaluated and implemented a 12-week centre- and home-based hybrid cardiac rehabilitation programme, including multidisciplinary care and physical activity sessions. Adolescent and young adult CHD patients with impaired cardiopulmonary fitness were randomly assigned to either the intervention (i.e. cardiac rehabilitation) or the standard of care. The primary outcome was the change in HRQoL from baseline to 12-month follow-up in an intention-to-treat analysis. The secondary outcomes were the change in cardiovascular parameters, cardiopulmonary fitness, and mental health. The expected number of 142 patients was enroled in the study (mean age 17.4 ± 3.4 years, 52% female). Patients assigned to the intervention had a significant positive change in HRQoL total score [mean difference 3.8; 95% confidence interval (CI) 0.2; 7.3; P = .038; effect size 0.34], body mass index [mean difference −0.7 kg/m2 (95% CI −1.3; −0.1); P = .022; effect size 0.41], level of physical activity [mean difference 2.5 (95% CI 0.1; 5); P = .044; effect size 0.39], and disease knowledge [mean difference 2.7 (95% CI 0.8; 4.6); P = .007; effect size 0.51]. The per-protocol analysis confirmed these results with a higher magnitude of differences. Acceptability, safety, and short-time effect of the intervention were good to excellent. This early hybrid cardiac rehabilitation programme improved HRQoL, body mass index, physical activity, and disease knowledge, in youth with CHD, opening up the possibility for the QUALIREHAB programme to be rolled out to the adult population of CHD and non-congenital cardiac disease. The long-term beneficial effect of the 12-week centre-based and home-based hybrid cardiac rehabilitation programme on adolescents and young adults with CHD was observed on HRQoL (primary outcome), BMI, physical activity, and disease knowledge, opening up the possibility for the QUALIREHAB programme to be rolled out to the adult population of CHD and non-congenital cardiac disease. BMI, body mass index; CHD, congenital heart disease; HRQoL, health-related quality of life.
- Open Access
- 1 November 2023
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 2 (11)
Aberrant mitochondrial dynamics contributes to diaphragmatic weakness induced by mechanical ventilation
In critical care patients, the “”temporary inactivity of the diaphragm caused by mechanical ventilation (MV) triggers a series of events leading to diaphragmatic dysfunction and atrophy, commonly known as ventilator-induced diaphragm dysfunction (VIDD). While mitochondrial dysfunction related to oxidative stress is recognized as a crucial factor in VIDD, the exact molecular mechanism remains poorly understood. In this study, we observe that 6 h of MV triggers aberrant mitochondrial dynamics, resulting in a reduction in mitochondrial size and interaction, associated with increased expression of dynamin-related protein 1 (DRP1). This effect can be prevented by P110, a molecule that inhibits the recruitment of DRP1 to the mitochondrial membrane. Furthermore, isolated mitochondria from the diaphragms of ventilated patients exhibited increased production of reactive oxygen species (ROS). These mitochondrial changes were associated with the rapid oxidation of type 1 ryanodine receptor (RyR1) and a decrease in the stabilizing subunit calstabin 1. Subsequently, we observed that the sarcoplasmic reticulum (SR) in the ventilated diaphragms showed increased calcium leakage and reduced contractile function. Importantly, the mitochondrial fission inhibitor P110 effectively prevented all of these alterations. Taken together, the results of our study illustrate that MV leads, in the diaphragm, to both mitochondrial fragmentation and dysfunction, linked to the up-/down-regulation of 320 proteins, as assessed through global comprehensive quantitative proteomics analysis, primarily associated with mitochondrial function. These outcomes underscore the significance of developing compounds aimed at modulating the balance between mitochondrial fission and fusion as potential interventions to mitigate VIDD in human patients.
- 1 November 2023
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 2 (11)
Open AccessAberrant mitochondrial dynamics contributes to diaphragmatic weakness induced by mechanical ventilation
In critical care patients, the “”temporary inactivity of the diaphragm caused by mechanical ventilation (MV) triggers a series of events leading to diaphragmatic dysfunction and atrophy, commonly known as ventilator-induced diaphragm dysfunction (VIDD). While mitochondrial dysfunction related to oxidative stress is recognized as a crucial factor in VIDD, the exact molecular mechanism remains poorly understood. In this study, we observe that 6 h of MV triggers aberrant mitochondrial dynamics, resulting in a reduction in mitochondrial size and interaction, associated with increased expression of dynamin-related protein 1 (DRP1). This effect can be prevented by P110, a molecule that inhibits the recruitment of DRP1 to the mitochondrial membrane. Furthermore, isolated mitochondria from the diaphragms of ventilated patients exhibited increased production of reactive oxygen species (ROS). These mitochondrial changes were associated with the rapid oxidation of type 1 ryanodine receptor (RyR1) and a decrease in the stabilizing subunit calstabin 1. Subsequently, we observed that the sarcoplasmic reticulum (SR) in the ventilated diaphragms showed increased calcium leakage and reduced contractile function. Importantly, the mitochondrial fission inhibitor P110 effectively prevented all of these alterations. Taken together, the results of our study illustrate that MV leads, in the diaphragm, to both mitochondrial fragmentation and dysfunction, linked to the up-/down-regulation of 320 proteins, as assessed through global comprehensive quantitative proteomics analysis, primarily associated with mitochondrial function. These outcomes underscore the significance of developing compounds aimed at modulating the balance between mitochondrial fission and fusion as potential interventions to mitigate VIDD in human patients.
- Open Access
- 30 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (23) , 12985
Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients
Duchenne muscular dystrophy (DMD) is characterized by progressive muscle wasting following repeated muscle damage and inadequate regeneration. Impaired myogenesis and differentiation play a major role in DMD as well as intracellular calcium (Ca2+) mishandling. Ca2+ release from the sarcoplasmic reticulum is mostly mediated by the type 1 ryanodine receptor (RYR1) that is required for skeletal muscle differentiation in animals. The study objective was to determine whether altered RYR1-mediated Ca2+ release contributes to myogenic differentiation impairment in DMD patients. The comparison of primary cultured myoblasts from six boys with DMD and five healthy controls highlighted delayed myoblast differentiation in DMD. Silencing RYR1 expression using specific si-RNA in a healthy control induced a similar delayed differentiation. In DMD myotubes, resting intracellular Ca2+ concentration was increased, but RYR1-mediated Ca2+ release was not changed compared with control myotubes. Incubation with the RYR-calstabin interaction stabilizer S107 decreased resting Ca2+ concentration in DMD myotubes to control values and improved calstabin1 binding to the RYR1 complex. S107 also improved myogenic differentiation in DMD. Furthermore, intracellular Ca2+ concentration was correlated with endomysial fibrosis, which is the only myopathologic parameter associated with poor motor outcome in patients with DMD. This suggested a potential relationship between RYR1 dysfunction and motor impairment. Our study highlights RYR1-mediated Ca2+ leakage in human DMD myotubes and its key role in myogenic differentiation impairment. RYR1 stabilization may be an interesting adjunctive therapeutic strategy in DMD.
- 30 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (23) , 12985
Open AccessSkeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients
Duchenne muscular dystrophy (DMD) is characterized by progressive muscle wasting following repeated muscle damage and inadequate regeneration. Impaired myogenesis and differentiation play a major role in DMD as well as intracellular calcium (Ca2+) mishandling. Ca2+ release from the sarcoplasmic reticulum is mostly mediated by the type 1 ryanodine receptor (RYR1) that is required for skeletal muscle differentiation in animals. The study objective was to determine whether altered RYR1-mediated Ca2+ release contributes to myogenic differentiation impairment in DMD patients. The comparison of primary cultured myoblasts from six boys with DMD and five healthy controls highlighted delayed myoblast differentiation in DMD. Silencing RYR1 expression using specific si-RNA in a healthy control induced a similar delayed differentiation. In DMD myotubes, resting intracellular Ca2+ concentration was increased, but RYR1-mediated Ca2+ release was not changed compared with control myotubes. Incubation with the RYR-calstabin interaction stabilizer S107 decreased resting Ca2+ concentration in DMD myotubes to control values and improved calstabin1 binding to the RYR1 complex. S107 also improved myogenic differentiation in DMD. Furthermore, intracellular Ca2+ concentration was correlated with endomysial fibrosis, which is the only myopathologic parameter associated with poor motor outcome in patients with DMD. This suggested a potential relationship between RYR1 dysfunction and motor impairment. Our study highlights RYR1-mediated Ca2+ leakage in human DMD myotubes and its key role in myogenic differentiation impairment. RYR1 stabilization may be an interesting adjunctive therapeutic strategy in DMD.
- Open Access
- 28 July 2021
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 19 (1) , 1-9
Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods
Background: Advances in paediatric cardiology have improved the prognosis of children with inherited cardiac disorders. However, health-related quality of life (QoL) and physical activity have been scarcely analysed in children with inherited cardiac arrhythmia or inherited cardiomyopathy. Moreover, current guidelines on the eligibility of young athletes with inherited cardiac disorders for sports participation mainly rely on expert opinions and remain controversial.Methods: The QUALIMYORYTHM trial is a multicentre observational controlled study. The main objective is to compare the QoL of children aged 6 to 17 years old with inherited cardiac arrhythmia (long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, or arrhythmogenic right ventricular dysplasia), or inherited cardiomyopathy (hypertrophic, dilated, or restrictive cardiomyopathy), to that of age and gender-matched healthy subjects. The secondary objective is to assess their QoL according to the disease’s clinical and genetic characteristics, the level of physical activity and motivation for sports, the exercise capacity, and the socio-demographic data. Participants will wear a fitness tracker (ActiGraph GT3X accelerometer) for 2 weeks. A total of 214 children are required to observe a significant difference of 7 ± 15 points in the PedsQL, with a power of 90% and an alpha risk of 5%.Discussion: After focusing on the survival in children with inherited cardiac disorders, current research is expanding to patient-reported outcomes and secondary prevention. The QUALIMYORYTHM trial intends to improve the level of evidence for future guidelines on sports eligibility in this population.Trial registrationClinicalTrials.gov Identifier: NCT04712136, registered on January 15th, 2021 (https://clinicaltrials.gov/ct2/show/NCT04712136).
- 28 July 2021
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 19 (1) , 1-9
Open AccessHealth-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods
Background: Advances in paediatric cardiology have improved the prognosis of children with inherited cardiac disorders. However, health-related quality of life (QoL) and physical activity have been scarcely analysed in children with inherited cardiac arrhythmia or inherited cardiomyopathy. Moreover, current guidelines on the eligibility of young athletes with inherited cardiac disorders for sports participation mainly rely on expert opinions and remain controversial.Methods: The QUALIMYORYTHM trial is a multicentre observational controlled study. The main objective is to compare the QoL of children aged 6 to 17 years old with inherited cardiac arrhythmia (long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, or arrhythmogenic right ventricular dysplasia), or inherited cardiomyopathy (hypertrophic, dilated, or restrictive cardiomyopathy), to that of age and gender-matched healthy subjects. The secondary objective is to assess their QoL according to the disease’s clinical and genetic characteristics, the level of physical activity and motivation for sports, the exercise capacity, and the socio-demographic data. Participants will wear a fitness tracker (ActiGraph GT3X accelerometer) for 2 weeks. A total of 214 children are required to observe a significant difference of 7 ± 15 points in the PedsQL, with a power of 90% and an alpha risk of 5%.Discussion: After focusing on the survival in children with inherited cardiac disorders, current research is expanding to patient-reported outcomes and secondary prevention. The QUALIMYORYTHM trial intends to improve the level of evidence for future guidelines on sports eligibility in this population.Trial registrationClinicalTrials.gov Identifier: NCT04712136, registered on January 15th, 2021 (https://clinicaltrials.gov/ct2/show/NCT04712136).